Home > E. Pathology by systems > Digestive system > Liver and pancreatobiliary system > Pancreas > MEN1-associated pancreatic neuroendocrine tumor
MEN1-associated pancreatic neuroendocrine tumor
Monday 2 July 2012
MEN-1 syndrome pancreatic neuroendocrine tumors
Pathology
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. (22575867)
References
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. de Wilde RF, Heaphy CM, Maitra A, Meeker AK, Edil BH, Wolfgang CL, Ellison TA, Schulick RD, Molenaar IQ, Valk GD, Vriens MR, Borel Rinkes IH, Offerhaus GJ, Hruban RH, Matsukuma KE. Mod Pathol. 2012 May 11. PMID: 22575867